PSA- Novartis confirms its Valsartan-containing meds in Egypt are safe for consumption: Novartis Pharma said yesterday that none of its Valsartan-containing meds in Egypt were recalled from the market. The pharma producer explained that blood pressure medication containing impure Valsartan, which is being recalled by order of the Health Ministry, was manufactured by a Chinese company that is not affiliated in any way with Novartis. “Novartis Pharma manufactures Valsartan API in its own manufacturing sites and does not rely on any external manufacturers,” the company said in a press release (pdf).
More from Enterprise
Banque du Caire’s blockbuster IPO holds firm against EGX selloff
The IFC and the EBRD are in for USD 100…
Electricity Ministry studies changing how your electricity bill gets calculated
The plan is still under study, and neither of the…
Egypt’s funds crossed EGP 500 bn in 3Q on retail money and a stalling core
Money market funds stalled while retail piled into equity, index,…
DPI closes Egypt-born fintech fund Nclude at USD 112 mn
The final close adds roughly USD 7 mn to a…